EB IP HYBRITABS B V has a total of 17 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2012. It filed its patents most often in Australia, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals are SPAIN PHARMA S A, Jiangxi puzheng pharmaceutical co ltd and HUANG YAJUN.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | China | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Republic of Korea | 2 | |
#5 | New Zealand | 2 | |
#6 | United States | 2 | |
#7 | Canada | 1 | |
#8 | EAPO (Eurasian Patent Organization) | 1 | |
#9 | Mexico | 1 | |
#10 | Singapore | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Frijlink Henderik Willem | 16 |
#2 | Eissens Anko Cornelus | 15 |
#3 | De Leede Leonardus Gerardus Jozef | 15 |
#4 | Tuiten Jan Johan Adriaan | 8 |
#5 | Williams Mark | 8 |
#6 | Bloemers Johannes Martinus Maria | 8 |
#7 | Henderik Willem Frijlink | 1 |
#8 | Johannes Martinus Maria Bloemers | 1 |
#9 | Deleede Leonardus Gerardus Jozef | 1 |
#10 | Eissens Anko Cornelis | 1 |
Publication | Filing date | Title |
---|---|---|
EP3248592A1 | Process for the preparation of drug delivery systems having a testosterone compound present in an outer layer or part, as well as such drug delivery systems | |
NZ717187A | Drug delivery system |